leukostrat flt3 mutation kit (Invivoscribe Inc)
86
Structured Review
Invivoscribe Inc
leukostrat flt3 mutation kit
Leukostrat Flt3 Mutation Kit, supplied by Invivoscribe Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukostrat+flt3+mutation+kit/assay+cdx+flt3+leukostrat+mutation/10__1016_slash_j__humgen__2025__201516-65-17-21
Average 86 stars, based on 1 article reviews
Leukostrat Flt3 Mutation Kit, supplied by Invivoscribe Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukostrat+flt3+mutation+kit/assay+cdx+flt3+leukostrat+mutation/10__1016_slash_j__humgen__2025__201516-65-17-21
Average 86 stars, based on 1 article reviews
leukostrat flt3 mutation kit - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
other:Article Title: Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia. Article Snippet: FLT3-ITD was analyzed using PCR and Mutagenesis:Article Title: Low GOPC mRNA expression is a novel candidate associated with increased risk of acute myeloid leukemia Article Snippet: Cytogenetic analysis included detection of three cytogenetic abnormalities (RUNX1::RUNX1T1, CBFB::MYH11, and PML:: RARA) through fluorescence in situ Hybridization (FISH) analysis using double translocation/fusion probes (D-5817-100-OG [8q21], D-5126-100-OG [16p13.1/16q22], and D-5998-100-OG [15q17], respectively) following the manufacturer instructions (Metasystems, Germany). .. To determine FLT3(ITD) and NPM1 mutation status, real-time polymerase chain reaction (RT-PCR)-based testing was conducted using the Real-time Polymerase Chain Reaction:Article Title: Low GOPC mRNA expression is a novel candidate associated with increased risk of acute myeloid leukemia Article Snippet: Cytogenetic analysis included detection of three cytogenetic abnormalities (RUNX1::RUNX1T1, CBFB::MYH11, and PML:: RARA) through fluorescence in situ Hybridization (FISH) analysis using double translocation/fusion probes (D-5817-100-OG [8q21], D-5126-100-OG [16p13.1/16q22], and D-5998-100-OG [15q17], respectively) following the manufacturer instructions (Metasystems, Germany). .. To determine FLT3(ITD) and NPM1 mutation status, real-time polymerase chain reaction (RT-PCR)-based testing was conducted using the |